Do vascular compartments differ in the development of chronic rejection? AT1 blocker candesartan versus Ace blocker enalapril in an experimental heart transplant model

Journal of Heart and Lung Transplantation

Volumn 20, Issue 10, 2001, Pages 1092-1098

  Richter, Marcus ^a,b,d   Richter, Heike ^b   Skupin, Manfred ^b   Mohr, Friedrich Wilhelm ^a   Olbrich, Hans Georg ^b,c  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c St Barbara Hospital   (Germany)

^d Experiment Heart Transplant Group   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN; CYCLOSPORIN; ENALAPRIL;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL OCCLUSION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; ENZYME LOCALIZATION; GRAFT REJECTION; HEART GRAFT; HISTOCOMPATIBILITY COMPLEX; IMMUNOSUPPRESSIVE TREATMENT; ISOGRAFT; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BENZIMIDAZOLES; CYCLOSPORINE; ENALAPRIL; GRAFT REJECTION; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; IMMUNOSUPPRESSIVE AGENTS; MODELS, ANIMAL; PREOPERATIVE CARE; RATS; RATS, INBRED F344; RATS, INBRED LEW; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

EID: 0034814743     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(01)00315-1     Document Type: Article

References (42)

1. Endothelial and smooth muscle cells express leucocyte adhesion molecules heterogeneously during acute rejection of rabbit cardiac allografts
2. Cardiac allograft vasculopathy: Current concepts, recent developments and further directions
3. The Registery of the International Society for Heart and Lung Transplantation: Ninth official report - 1993
4. Myocardial changes in cardiac transplant-associated coronary arteriosclerosis: Potential for timely diagnosis
5. The pathogenesis of atherosclerosis: A perspective for the 1990's
6. Local expression and pathobiological role of renin-angiotensin in the blood vessels and heart
7. Angiotensin II induces vascular smooth muscle cell replication independent of blood pressure
8. Nitric oxide inhibits angiotensin II induced migration of rat aortic smooth muscle cell: Role of cyclic-nucleotides and angiotensin I receptor
9. Molecular biology of angiotensin II receptors: An overview
10. Inositol phosphatases and cell signaling
11. Angiotensin II-induced phosphatidylcholine hydrolysis in cultured vascular smooth muscle cells. Regulation and localization
12. Stimulation of prostaglandin E synthesis cultured in human umbilical vein smooth muscle cells
13. Angiotensin II and α-adrenergic agonists inhibit liver adenylat cyclase
14. Angiotensin-receptor signaling in cultured vascular smooth muscle cells
15. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury
16. Captopril reduces graft coronary artery disease in a rat heterotopic transplant model
17. Angiotensin-converting enzyme: New concepts concerning its biological role
18. Angiotensin converting enzyme vascular endothelial localization
19. Induction of angiotensin converting enzyme in the neointimal after vascular injury: Possible role in restenosis
20. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease
21. Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of the rat aorta
22. Angiotensin II receptors and angiotensin II receptors antagonists
23. Experimental graft arteriosclerosis. I. The Lewis to Fisher F344 allograft model
24. Improved technique of heart transplantation in rats
25. Heart transplantation in rats
26. A working formulation for the standardisation of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group
27. Inhibitors of the angiotensin-converting enzyme prevent myointimal injury after vascular injury
28. Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries
29. New approach in the therapy of chronic rejection? ACE-and AT1 blocker reduce the development of chronic rejection after cardiac transplantation in a rat model
30. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall
31. Localisation and differential regulation of angiotensinogen mRNA expression in the vessel wall
32. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: Gain-of-function study using gene transfer
33. The potential role of angiotensin II in the vasculature
34. Differential gene expression and regulation of type-1 angiotensin II receptor subtypes in the rat
35. Downregulation of cardiac AT1 receptor expression and angiotensin II concentrations after long-term blockade of the rennin-angiotensin system in cardiomyopathic hamsters
36. Angiotensin II formation from ACE and chymase in human and animal hearts: Methods and species consideration
37. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation
38. Effect of captopril on the bradykinin-induced release of prostacyclin from guinca pig lung or bovine aortic endothelial cell
39. Hormone interaction in the isolated rabbit heart. Synthesis and coronary vasomotor effects of prostaglandins, angiotensin and bradykinin
40. 1 receptor
41. Cellular localisation and regional distribution of an angiotensin II forming chymase in the heart
42. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II